Conducting clinical research studies with
SKILL, KNOWLEDGE and SAFETY.
Call to participate
860.443.4567

Posts Tagged ‘ Obsessive Compulsive Disorder ’

OCD Study Launched

Wednesday, February 17th, 2021

 

Dr. Laurence Radin will be serving as the Principal Investigator of a clinical trial evaluating an adjunct (add-on) study product for OCD.  Andrea Stewart, APRN, Diane Palmer, RN and Kelley Sanok, RN round out the study team.  If you are unsure if you might be an eligible participant for a local research study, you might have some questions.

Frequently asked questions

What is the purpose of a clinical trial?

Clinical studies (also called clinical trials) are used to learn about the safety and effectiveness of possible new medications, medical devices, and medical procedures.  Although there are many types of clinical trials, all United States-based clinical trials must conform to strict rules set forth by the U.S. Food and Drug Administration (FDA).  These rules help protect the rights and safety of those who volunteer to take part in clinical trials.

Who is conducting this study?

The study is being conducted on behalf of Biohaven Pharmaceuticals by multiple sites (research clinics or hospitals) across the United States with trained, qualified, medical specialists.

Will I have to pay anything to participate?

No. If you qualify and are chosen to participate, you will receive all study-related care, including investigational study drug, at no cost to you.

I’m not sure if I have OCD, can I still participate?

If you think you have OCD, a clinician will evaluate you if you are eligible.

How many people will participate in this study?

About 2,000 people will participate in this study.